Core Insights - The "Second International Breast Cancer Research Forum" hosted by Shandong University Qilu Second Hospital focused on breast cancer research, clinical diagnosis, and precision prevention strategies, featuring over 20 expert presentations from 12 countries and regions [1][2][7] Group 1: Event Overview - The forum aimed to create a high-level academic exchange platform addressing key areas in breast cancer research, including clinical diagnosis and innovative treatment methods [1] - Key figures from Shandong University and international experts participated, emphasizing the importance of global collaboration in breast cancer prevention and treatment [2] Group 2: Institutional Goals and Achievements - Shandong University Qilu Second Hospital is transitioning from a disease-centered approach to a health-centered strategy, focusing on medical innovation, talent cultivation, and research成果转化 [1][2] - The hospital showcased its achievements in breast cancer cohort construction, biobank standardization, and digital medicine platform development [2] Group 3: Academic Contributions - The forum featured presentations on various topics, including molecular pathology, treatment innovations, and AI-assisted medical imaging, highlighting the comprehensive nature of breast cancer research [3][4][5][6] - Notable presentations included discussions on the Hippo signaling pathway, metabolic vulnerabilities in luminal breast cancer, and advancements in cell and gene therapy for endocrine diseases [3][4][5] Group 4: Future Directions - The collaboration between the forum and the inaugural editorial board meeting of "Molecular and Digital Medicine" aims to enhance interdisciplinary integration and accelerate the translation of research成果 into clinical practice [7]

Core Insights - The newly elected academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering highlight a concentration in the field of oncology and major diseases, with a total of 73 and 71 academicians elected respectively [1][3]. Group 1: Elected Academicians - Among the newly elected academicians, notable experts in clinical medicine include Zhou Jian from Zhongshan Hospital affiliated with Fudan University and Fang Jingyuan from Renji Hospital affiliated with Shanghai Jiao Tong University [1]. - Other elected academicians in clinical medicine include Cai Xiujun from Shao Yifu Hospital affiliated with Zhejiang University and Wang Yongjun from Beijing Tiantan Hospital affiliated with Capital Medical University [1]. Group 2: Focus on Liver Cancer - Zhou Jian specializes in clinical and basic research on liver cancer and has received the National Science and Technology Progress Award five times; he emphasizes that liver cancer can be managed as a chronic disease [3]. - Zhou Jian and Fang Jingyuan published a significant report in The Lancet, indicating that at least 60% of liver cancer cases are preventable by reducing risk factors such as viral hepatitis and alcohol consumption [3]. - A miRNA early diagnosis model for liver cancer developed by Zhou Jian and Fang Jingyuan has been successfully transformed into a clinical application, with over 5 million tests conducted, significantly improving early detection rates compared to traditional markers [3]. Group 3: Focus on Gastrointestinal Cancer - Fang Jingyuan has made significant contributions in the field of gastrointestinal cancer, particularly in early warning, diagnosis, prevention, and comprehensive treatment [4]. - Fang Jingyuan has innovatively analyzed gut microbiota to assess the effectiveness of postoperative chemotherapy and immunotherapy for colorectal cancer [4].

Core Insights - Obesity is a significant global public health issue, with a retrospective study revealing a 69.5% incidence of weight regain among patients who underwent sleeve gastrectomy (SG) [6][7] - The study identifies the third year post-surgery as a critical period for weight rebound, with 41.7% of patients experiencing a weight regain of 20% or more of their maximum weight loss, meeting the criteria for weight regain (WR) [6][7][8] Study Overview - The research included 676 patients who underwent SG at Shanghai Jiao Tong University from January 2011 to June 2022, with a median follow-up of three years [6][7] - Factors associated with higher postoperative total weight loss percentage (%TWL) included baseline age, initial BMI, male gender, and absence of hypertension [7] - Among 540 patients with complete follow-up at 1, 3, and 5 years, the rate of weight regain increased from 21.7% at year three to 32.6% at year five [7] Weight Change Patterns - Patients were categorized into three groups based on weight change trajectories: significant weight loss, moderate weight loss, and minimal weight loss [7] - The significant weight loss group had higher baseline BMI, waist circumference, fasting insulin, and insulin resistance index (HOMA-IR) compared to the minimal weight loss group [7] Implications for Future Research - The findings provide a scientific basis for identifying high-risk patients and developing preventive strategies against weight regain after SG [8]

Core Viewpoint - A special collection on epidemiological research titled "Advancing China and International Cohort Studies" was recently released at the First Hospital of Jilin University in Changchun, where researchers from multiple countries gathered to discuss issues related to large-scale cohort studies [3]. Group 1 - The event highlighted the importance of international collaboration in epidemiological research [3]. - Researchers focused on addressing challenges and opportunities in conducting large-scale cohort studies [3].

Core Insights - The establishment of the first clinical research center for brain-machine interfaces in Shanxi marks a significant advancement in the treatment of difficult-to-treat neurological conditions, with the potential to benefit many patients [1][2] - The center will focus on innovative treatments such as deep brain stimulation (DBS) and intelligent perceivable brain pacemakers, which can adjust brain function and collect brain electrical signals [1][2] Group 1 - The first patient, Ms. Zhao, experienced significant improvement in her condition after undergoing DBS, highlighting the potential of this technology for patients with severe obsessive-compulsive disorder [1] - The center is equipped with advanced facilities, including a composite operating room and intelligent surgical robots, to support its multidisciplinary approach [2] - The center aims to collaborate with universities and enterprises to explore applications of brain-machine interfaces in various neurological disorders, including epilepsy, Parkinson's disease, dementia, and obsessive-compulsive disorder [2] Group 2 - The center's multidisciplinary team includes specialists from neurosurgery, neurology, mental health, rehabilitation medicine, and medical imaging, enhancing the scope of treatment options available [2] - Future plans include using neurostimulation techniques to aid in the recovery of patients with consciousness disorders, such as those in a vegetative state [2] - The innovative approach of the center represents a shift towards personalized treatment pathways for patients with neurological conditions [1][2]

Core Viewpoint - The recent research from the University of California, Berkeley, challenges the traditional belief that high-calorie foods are the main cause of obesity, suggesting that the pleasure derived from eating can play a positive role in weight management [4][7]. Group 1: Research Findings - The study titled "Changes in neurotensin signalling drive hedonic devaluation in obesity" reveals that the enjoyment of food can help maintain energy balance, redefining the relationship between food pleasure and obesity [4][7]. - High-fat diets were shown to impair the brain's reward system, leading to reduced appetite for high-calorie foods in obese mice, despite weight gain [9][11]. - The research identified neurotensin (NTS) as a key player in this process, with high-fat diets significantly suppressing NTS expression, which is crucial for enhancing dopamine neuron activity during food enjoyment [11][12]. Group 2: Implications for Weight Management - Restoring NTS levels through dietary intervention or gene therapy resulted in obese mice regaining normal food responses, reducing overall food intake, and improving anxiety symptoms [12]. - The findings suggest a shift from traditional weight loss strategies focused on appetite suppression to approaches that enhance the brain's reward mechanisms related to food enjoyment, potentially leading to the development of "happy dieting" therapies [12]. - This research opens new avenues for addressing obesity and related metabolic disorders, emphasizing the intersection of neuroscience and nutrition [12].

Core Insights - The article discusses a significant research paper published in Cell Genomics, focusing on the multi-omic underpinnings of heterogeneous aging across multiple organ systems [4][6]. - The research aims to shift the paradigm of age-related disease management from a "divide and conquer" approach to a "unified prevention" strategy by understanding the molecular mechanisms of aging [7][9]. Research Objectives - The study aims to clarify the genetic associations between organ-specific aging and blood-based epigenetic aging, revealing phenotypic clusters related to heterogeneous aging across multiple organ systems [7]. - It seeks to identify candidate gene drug targets associated with these heterogeneous aging processes and evaluate opportunities for repurposing existing drugs [7]. - The research intends to uncover downstream proteomic and metabolomic effects driven by organ-specific and blood-based epigenetic aging, identifying detectable biomarkers [7]. - The study integrates findings to map the interaction networks of heterogeneous aging across multiple organ systems and their potential cross-layer molecular regulatory mechanisms [7][10]. Key Findings - The research team developed a framework based on R/Shiny, accessible online, providing a comprehensive multi-omic molecular map of heterogeneous aging [9]. - The study advances the understanding of aging heterogeneity, offering insights for precision medical strategies aimed at delaying organ-specific aging and preventing or treating related chronic diseases [9][10]. - Heterogeneous aging phenotypic clusters exhibit distinct biological characteristics, and genomic approaches have identified priority drug targets for addressing this aging heterogeneity [10].

Core Insights - Apple CEO Tim Cook announced a collaboration with Beijing Anzhen Hospital and the American Heart Association to study the application of Apple Watch in managing heart failure patients [2][3] - This partnership aims to innovate heart disease management by integrating technology with medical expertise, marking a significant step in Apple's strategy to deepen its presence in the Chinese healthcare sector [2][3] Group 1: Collaboration Details - The collaboration leverages the strengths of each party: Apple provides technology and data support, Beijing Anzhen Hospital offers clinical resources, and the American Heart Association contributes global expertise [5][4] - The study focuses on two main objectives: building a network of clinical experts to support health initiatives and establishing a foundation for future health research in China [3][6] Group 2: Research Goals - The research aims to determine if wearable technology can optimize guideline-directed medical therapy (GDMT) for heart failure patients with atrial fibrillation [6][7] - It will involve over 200 patients equipped with Apple Watches for 90 days to analyze data on physical activity and sleep, assessing the device's ability to predict health risks [6][7] Group 3: Patient and Clinical Impact - For patients, the study shifts from passive to active health management, allowing real-time monitoring and timely medical intervention, thus improving quality of life [7][8] - Clinicians gain access to continuous patient data, enabling personalized treatment plans and enhancing clinical research opportunities [7][8] Group 4: Industry Implications - This collaboration exemplifies the potential of wearable devices to transform healthcare by extending monitoring from hospitals to homes, promoting a preventive healthcare model [8][9] - The partnership sets a precedent for future collaborations between technology companies and healthcare institutions, providing a model for addressing critical health management issues [8][9] Group 5: Global Health Perspective - The research aims to contribute to global cardiovascular health solutions, leveraging China's extensive patient population and clinical experience [9][10] - Apple's vision emphasizes improving human life quality through technology, with the potential for wearable devices to play a significant role in health management across various diseases [10]

Core Insights - The "Four Major Chronic Diseases" National Science and Technology Major Project has been launched in Jiangsu Taizhou, focusing on cancer, cardiovascular, respiratory, and metabolic disease prevention and control [1] Group 1: Project Overview - The project, approved in May 2023, is the only regional plan selected in the Yangtze River Delta and has a four-year implementation period [1] - The project aims to address key challenges in the prevention and control of chronic diseases by leveraging existing research capabilities [1] Group 2: Innovative Approaches - The project is based on the previous "Star Network Plan," which promotes an integrated chronic disease prevention and control model [1] - The core concept of the "Star Network Plan" is to empower grassroots healthcare through "Artificial Intelligence + Healthcare," shifting the focus from disease treatment to health promotion [1] Group 3: Healthcare Network Structure - The project aims to establish a four-tier chronic disease management network consisting of regional medical centers, county hospitals, central hospitals, and grassroots clinics [1] - It utilizes technologies such as the Internet of Things, artificial intelligence, and mobile wearable devices to enhance grassroots healthcare institutions [1] Group 4: Comprehensive Service Model - The initiative provides a full-process individualized prevention and treatment service, including prevention, screening, rescue, treatment, and rehabilitation [1] - The goal is to encourage chronic disease patients to return to community health services and to reintegrate rural doctors into the primary prevention and control efforts [1]

Core Viewpoint - The collaboration between Shanghai University of Traditional Chinese Medicine's Longhua Hospital and the China Aromatherapy Research Institute aims to explore the potential of medicinal plant-derived essential oils in managing pain associated with pancreatic cancer, focusing on non-pharmacological interventions [1] Group 1: Research Project Overview - The clinical observation study will evaluate the efficacy of essential oils through external application and inhalation methods in cancer pain management [1] - The project is based on the traditional Chinese medicine theory of "supporting the body to treat cancer" [1] - The research seeks to provide a high-access, low-burden solution to address pain, anxiety, and fear associated with tumors [1] Group 2: Institutional Roles - Longhua Hospital will lead the overall design and clinical implementation of the research, leveraging its extensive clinical experience in oncology [1] - The China Aromatherapy Research Institute will supply standardized natural plant essential oils and technical support, ensuring quality control throughout the research process [1] - This collaboration aims to establish a solid foundation for generating high-level evidence in evidence-based medicine [1] Group 3: Implications for Public Health - The study's findings are expected to offer new directions for psychosocial management of cancer in the public health sector [1] - The project addresses the challenges posed by current pain management protocols, which often face issues such as side effects and dependency [1]